|
Volumn 13, Issue 4, 2006, Pages 442-443
|
At the crossroads for retroperitoneal sarcomas: The future of clinical trials for this "orphan disease"
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER CHEMOTHERAPY;
CANCER CONTROL;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
EDITORIAL;
HUMAN;
INTRAOPERATIVE RADIOTHERAPY;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PREOPERATIVE CARE;
PROGNOSIS;
RARE DISEASE;
RETROPERITONEAL SARCOMA;
TREATMENT FAILURE;
TREATMENT OUTCOME;
CLINICAL TRIALS, PHASE III;
COMBINED MODALITY THERAPY;
FORECASTING;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
PREOPERATIVE CARE;
RETROPERITONEAL SPACE;
SARCOMA;
SOFT TISSUE NEOPLASMS;
|
EID: 33644980377
PISSN: 10689265
EISSN: 15344681
Source Type: Journal
DOI: 10.1245/ASO.2006.09.909 Document Type: Editorial |
Times cited : (12)
|
References (8)
|